146 related articles for article (PubMed ID: 37772680)
21. Torque teno virus loads after kidney transplantation predict allograft rejection but not viral infection.
van Rijn AL; Wunderink HF; Sidorov IA; de Brouwer CS; Kroes AC; Putter H; de Vries AP; Rotmans JI; Feltkamp MC
J Clin Virol; 2021 Jul; 140():104871. PubMed ID: 34089977
[TBL] [Abstract][Full Text] [Related]
22. The association of cytomegalovirus infection and cytomegalovirus serostatus with invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients: a systematic review and meta-analysis.
Chuleerarux N; Nematollahi S; Thongkam A; Dioverti MV; Manothummetha K; Torvorapanit P; Langsiri N; Worasilchai N; Plongla R; Chindamporn A; Sanguankeo A; Permpalung N
Clin Microbiol Infect; 2022 Mar; 28(3):332-344. PubMed ID: 34752926
[TBL] [Abstract][Full Text] [Related]
23. [Relationship between copies of cytomegalovirus in plasma and cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation].
Chen YH; Zhao XS; Liu KY; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang Y; Zhao T; Zhao XT; Huang XJ
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1540-3. PubMed ID: 19953881
[TBL] [Abstract][Full Text] [Related]
24. No correlation between Torque Teno virus viral load and BK virus replication after kidney transplantation.
Handala L; Descamps V; Morel V; Castelain S; François C; Duverlie G; Helle F; Brochot E
J Clin Virol; 2019 Jul; 116():4-6. PubMed ID: 30986626
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients Plasma.
Zanella MC; Vu DL; Hosszu-Fellous K; Neofytos D; Van Delden C; Turin L; Poncet A; Simonetta F; Masouridi-Levrat S; Chalandon Y; Cordey S; Kaiser L
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112908
[TBL] [Abstract][Full Text] [Related]
26. An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
Talaya A; Giménez E; Pascual MJ; Gago B; Piñana JL; Hernández-Boluda JC; Vázquez L; García M; Serrano D; Hernández M; Albert E; Solano C; Navarro D
Med Microbiol Immunol; 2020 Feb; 209(1):15-21. PubMed ID: 31478067
[TBL] [Abstract][Full Text] [Related]
27. Virome definition in cerebrospinal fluid of patients with neurological complications after hematopoietic stem cell transplantation.
Pou C; Barrientos-Somarribas M; Marin-Juan S; Bogdanovic G; Bjerkner A; Allander T; Gustafsson B; Andersson B
J Clin Virol; 2018 Nov; 108():112-120. PubMed ID: 30296744
[TBL] [Abstract][Full Text] [Related]
28. Development of a standardized real time PCR for Torque teno viruses (TTV) viral load detection and quantification: A new tool for immune monitoring.
Kulifaj D; Durgueil-Lariviere B; Meynier F; Munteanu E; Pichon N; Dubé M; Joannes M; Essig M; Hantz S; Barranger C; Alain S
J Clin Virol; 2018 Aug; 105():118-127. PubMed ID: 29957546
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients.
Talaya A; Giménez E; Vinuesa V; Pérez A; Amat P; Piñana JL; Albert E; Hernández-Boluda JC; Solano C; Navarro D
Med Microbiol Immunol; 2019 Aug; 208(3-4):405-414. PubMed ID: 30911925
[TBL] [Abstract][Full Text] [Related]
30. Monitoring of oral cytomegalovirus DNA shedding for the prediction of viral DNAemia in allogeneic hematopoietic stem cell transplant recipients.
Pascual T; Solano C; Torres I; Talaya A; Giménez E; Vinuesa V; Piñana JL; Hernández-Boluda JC; Pérez A; Navarro D
J Med Virol; 2018 Aug; 90(8):1375-1382. PubMed ID: 29663435
[TBL] [Abstract][Full Text] [Related]
31. Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR.
Krawczyk A; Ackermann J; Goitowski B; Trenschel R; Ditschkowski M; Timm J; Ottinger H; Beelen DW; Grüner N; Fiedler M
J Clin Virol; 2018; 99-100():61-66. PubMed ID: 29331844
[TBL] [Abstract][Full Text] [Related]
32. Spontaneously-resolving episodes of cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: Virological features and clinical outcomes.
Talaya A; Giménez E; Piñana JL; Albert E; Hernández-Boluda JC; Pérez A; Torres I; Solano C; Navarro D
J Med Virol; 2019 Jun; 91(6):1128-1135. PubMed ID: 30735250
[TBL] [Abstract][Full Text] [Related]
33. Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications.
Tey SK; Kennedy GA; Cromer D; Davenport MP; Walker S; Jones LI; Crough T; Durrant ST; Morton JA; Butler JP; Misra AK; Hill GR; Khanna R
PLoS One; 2013; 8(10):e74744. PubMed ID: 24146744
[TBL] [Abstract][Full Text] [Related]
34. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation.
Borchers S; Luther S; Lips U; Hahn N; Kontsendorn J; Stadler M; Buchholz S; Diedrich H; Eder M; Koehl U; Ganser A; Mischak-Weissinger E
Transpl Infect Dis; 2011 Jun; 13(3):222-36. PubMed ID: 21585633
[TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics and viral load patterns in children with cytomegalovirus gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
Kang HM; Kim SK; Ryu IH; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B
Bone Marrow Transplant; 2021 Nov; 56(11):2813-2819. PubMed ID: 34274956
[TBL] [Abstract][Full Text] [Related]
36. CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality.
Eberhardt KA; Jung V; Knops E; Heger E; Wirtz M; Steger G; Kaiser R; Affeldt P; Holtick U; Klein F; Scheid C; Di Cristanziano V
Bone Marrow Transplant; 2023 Jun; 58(6):639-646. PubMed ID: 36869190
[TBL] [Abstract][Full Text] [Related]
37. Time to initiation of pre-emptive therapy for cytomegalovirus impacts overall survival in pediatric hematopoietic stem cell transplant recipients.
Camacho-Bydume C; Mauguen A; Rodriguez-Sanchez MI; Klein E; Kernan NA; Prockop S; Boelens JJ; Papanicolaou GA; Cancio M
Cytotherapy; 2022 Apr; 24(4):428-436. PubMed ID: 35042670
[TBL] [Abstract][Full Text] [Related]
38. Cytomegalovirus management after allogeneic hematopoietic stem cell transplantation: A mini-review.
Jerry Teng CL; Wang PN; Chen YC; Ko BS
J Microbiol Immunol Infect; 2021 Jun; 54(3):341-348. PubMed ID: 33514495
[TBL] [Abstract][Full Text] [Related]
39. [Clinical study of low cytomegalovirus viral load thresholds for preemptive antiviral therapy in hematopoietic cell transplant recipients].
Li L; Wang Y; Yan CH; Huang XJ
Zhonghua Nei Ke Za Zhi; 2018 Mar; 57(3):191-195. PubMed ID: 29518863
[No Abstract] [Full Text] [Related]
40. Torque teno virus viral load is related to age, CMV infection and HLA type but not to Alzheimer's disease.
Westman G; Schoofs C; Ingelsson M; Järhult JD; Muradrasoli S
PLoS One; 2020; 15(1):e0227670. PubMed ID: 31917803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
